Trevi Therapeutics, Inc. (TRVI)
16.64
-0.18
(-1.10%)
USD |
NASDAQ |
Sep 09, 16:00
16.64
0.00 (0.00%)
After-Hours: 16:07
Trevi Therapeutics Total Assets (Quarterly) : 330.52M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 330.52M |
| March 31, 2026 | 179.61M |
| December 31, 2025 | 193.62M |
| September 30, 2025 | 199.36M |
| June 30, 2025 | 208.34M |
| March 31, 2025 | 107.00M |
| December 31, 2024 | 110.90M |
| September 30, 2024 | 68.91M |
| June 30, 2024 | 73.81M |
| March 31, 2024 | 78.56M |
| December 31, 2023 | 89.40M |
| September 30, 2023 | 95.90M |
| June 30, 2023 | 100.98M |
| March 31, 2023 | 116.20M |
| December 31, 2022 | 123.02M |
| September 30, 2022 | 128.36M |
| June 30, 2022 | 81.41M |
| March 31, 2022 | 30.39M |
| Date | Value |
|---|---|
| December 31, 2021 | 38.48M |
| September 30, 2021 | 31.60M |
| June 30, 2021 | 39.15M |
| March 31, 2021 | 42.86M |
| December 31, 2020 | 47.13M |
| September 30, 2020 | 55.88M |
| June 30, 2020 | 47.01M |
| March 31, 2020 | 54.24M |
| December 31, 2019 | 60.00M |
| September 30, 2019 | 66.02M |
| June 30, 2019 | 75.12M |
| March 31, 2019 | 17.18M |
| December 31, 2018 | 10.53M |
| September 30, 2018 | 15.38M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 22.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.012M |
| Shareholders Equity (Quarterly) | 321.51M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 37.28 |
| Net Debt Paydown Yield | 0.00% |